• Heidelberglaan 100, UMC Utrecht

      3584 CX Utrecht

      Netherlands

    1990 …2025

    Research activity per year

    Personal profile

    Biography

    Prof. Jeanette Leusen, received her PhD in 1995 at the University of Amsterdam, The Netherlands. She became associate professor and head of the immunotherapy group of the University Medical Center in Utrecht in 2006, and head of the UMAB facility in 2012. She has co-authored more than 150 publications in peer-reviewed journals and is inventor on 13 patent applications. Her group of 24 FTE works on the mechanism of action of therapeutic antibodies, with a special interest in IgA as a novel class of antibody for the treatment of both malignant as infectious disease.

    Side activities

    Dr Leusen is the scientific founder of TigaTx in 2018, a spin-off company on engineered IgA as therapeutic antibody in oncology. She was employed by TigaTx as CSO from 2020 til 2022, and as senior advisor from 2022 til 2024.

    Dr Leusen is senior editor of several Immunology/cancer journals and was organizer of the FASEB meeting on Immunoreceptors of 2014 and 2016, and was vice chair of the Gordon Research Conference on Antibody Biology and Engineering in 2018, and main chair in 2022, https://www.grc.org/antibody-biology-and-engineering-conference/2022

    Fellowship & awards

    Dr Leusen holds several grants from Health Holland, KWF, Villa Joep! and industry.

    Education/Academic qualification

    PhD

    1 Jun 19911 Dec 1995

    Award Date: 13 Dec 1995

    Keywords

    • RM Therapeutics. Pharmacology
    • Antibody therapy
    • Fc receptors
    • IgA

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or